Management of Frequent Exercise-Induced Asthma

Introduction to Asthma Management

The American Thoracic Society guidelines state that requiring an inhaled short-acting beta-agonist daily or more frequently is an indication to initiate daily inhaled corticosteroid therapy, as it signals inadequate asthma control and the need for controller therapy 1, 2
The NAEPP guidelines note that using short-acting beta-agonists more than two days per week for symptom relief generally indicates inadequate control and the need to step up treatment 3, 4

Daily ICS therapy is the most effective anti-inflammatory treatment for exercise-induced bronchoconstriction, with the American Thoracic Society finding a mean maximum percent fall in FEV1 after exercise that was 10.98% less than placebo 1, 2
The maximum beneficial effect of ICS may take up to 4 weeks and is dose-dependent 1, 2
The American Thoracic Society recommends starting with low-dose ICS, equivalent to beclomethasone 200-400 mcg/day 4

The American Thoracic Society strongly recommends against daily LABA monotherapy for patients requiring daily SABA use, due to increased risk of asthma-related mortality and serious adverse effects 1, 2
LABAs should only be used in combination with ICS, never as monotherapy 1, 2

If unable or unwilling to use inhaled corticosteroids, montelukast is an appropriate alternative for mild persistent asthma 4
However, ICS remains superior to leukotriene receptor antagonists for most patients 4

If symptoms persist despite daily ICS therapy, the next step is adding a long-acting beta-agonist to ICS, providing clinically meaningful improvements in lung function and reduced need for rescue SABA 3, 4

After starting daily ICS, track how often rescue albuterol is needed, and contact a doctor if still needed more than twice weekly after 4 weeks 3, 4
Monitor peak flow if possible, which should improve over 2-4 weeks 1, 2

Using short-acting beta-agonists more than 2 days per week for symptom relief indicates inadequate asthma control and necessitates stepping up to daily controller medication, as recommended by the American Academy of Family Physicians 6

The American Academy of Family Physicians recommends continuing to use albuterol as needed for acute symptoms, but it should decrease to ≤2 days per week once ICS takes effect 6
Using a spacer with metered-dose inhalers and rinsing the mouth after ICS use reduces local side effects like oral thrush and dysphonia, as suggested by the American Academy of Allergy, Asthma, and Immunology 7

Ensuring proper inhaler technique is crucial, as many patients use inhalers incorrectly, which undermines treatment efficacy, and directly observing and coaching technique is recommended by the American Academy of Family Physicians 6